title: Management of supraventricular tachycardias.
authors: MRC Clinical Research Fellow and Cardiology Specialist Registrar in the International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, London.
authors: Sukhjinder S
authors: SS
authors: Nijjer
authors: BHF Clinical Research Fellow and Cardiology Specialty Registrar in the International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, London.
authors: S M Afzal
authors: SM
authors: Sohaib
authors: Senior Lecturer and Consultant in Cardiology and Cardiac Electrophysiology in the Cardiology Department, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London.
authors: Zachary I
authors: ZI
authors: Whinnett
authors: Consultant in Cardiology and Cardiac Electrophysiology in the Cardiology Department, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London.
authors: David C
authors: DC
authors: Lefroy
mesh_terms: D000241:Adenosine / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D015897:Comorbidity; D004562:Electrocardiography; D006801:Humans; D026902:Potassium Channel Blockers / Q000627:therapeutic use; D026941:Sodium Channel Blockers / Q000627:therapeutic use; D013617:Tachycardia, Supraventricular / Q000188:drug therapy*; D014700:Verapamil / Q000627:therapeutic use
chemical_list: D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D002121:Calcium Channel Blockers; D026902:Potassium Channel Blockers; D026941:Sodium Channel Blockers; D014700:Verapamil; D000241:Adenosine